| Year |
Citation |
Score |
| 2020 |
Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, et al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12. PMID 32102932 DOI: 10.1126/Scitranslmed.Aay7522 |
0.31 |
|
| 2019 |
Guo Y, Wang Y, Peng X, Coukos G, Li C. Abstract NT-099: NOVEL ANTIBODY DRUG CONJUGATE (ADC) AND COMPANION DIAGNOSTICS AGAINST CD248+ CANCER Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Nt-099 |
0.353 |
|
| 2017 |
Yang L, Zhang Y, Shan W, Hu Z, Yuan J, Pi J, Wang Y, Fan L, Tang Z, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, et al. Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Science Translational Medicine. 9. PMID 28747513 DOI: 10.1126/Scitranslmed.Aal1645 |
0.341 |
|
| 2016 |
Huang M, Liu T, Ma P, Mitteer RA, Zhang Z, Kim HJ, Yeo E, Zhang D, Cai P, Li C, Zhang L, Zhao B, Roccograndi L, O'Rourke DM, Dahmane N, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. The Journal of Clinical Investigation. PMID 27043280 DOI: 10.1172/Jci84876 |
0.327 |
|
| 2016 |
Ning C, Xie B, Zhang L, Li C, Shan W, Yang B, Luo X, Gu C, He Q, Jin H, Chen X, Zhang Z, Feng Y. Infiltrating macrophages induce ERα expression through an IL-17A-mediated epigenetic mechanism to sensitize endometrial cancer cells to estrogen. Cancer Research. PMID 26744532 DOI: 10.1158/0008-5472.Can-15-1260 |
0.31 |
|
| 2015 |
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40. PMID 26461095 DOI: 10.1016/J.Ccell.2015.09.006 |
0.318 |
|
| 2015 |
Santoro SP, Kim S, Motz GT, Alatzoglou D, Li C, Irving M, Powell DJ, Coukos G. T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer Immunology Research. 3: 68-84. PMID 25358763 DOI: 10.1158/2326-6066.Cir-14-0192 |
0.342 |
|
| 2014 |
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, Jean S, Li C, Huang Q, Katsaros D, Montone KT, et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 26: 344-57. PMID 25203321 DOI: 10.1016/J.Ccr.2014.07.009 |
0.333 |
|
| 2014 |
Li C, Wang J, Hu J, Feng Y, Hasegawa K, Peng X, Duan X, Zhao A, Mikitsh JL, Muzykantov VR, Chacko AM, Pryma DA, Dunn SM, Coukos G. Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget. 5: 6994-7012. PMID 25051365 DOI: 10.18632/Oncotarget.2188 |
0.351 |
|
| 2014 |
Matthaiou EI, Barar J, Sandaltzopoulos R, Li C, Coukos G, Omidi Y. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. International Journal of Nanomedicine. 9: 1855-70. PMID 24790428 DOI: 10.2147/Ijn.S51880 |
0.304 |
|
| 2014 |
Facciponte JG, Ugel S, De Sanctis F, Li C, Wang L, Nair G, Sehgal S, Raj A, Matthaiou E, Coukos G, Facciabene A. Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature. The Journal of Clinical Investigation. 124: 1497-511. PMID 24642465 DOI: 10.1172/Jci67382 |
0.329 |
|
| 2014 |
Li C, Chacko AM, Hu J, Hasegawa K, Swails J, Grasso L, El-Deiry WS, Nicolaides N, Muzykantov VR, Divgi CR, Coukos G. Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model. Cancer Biology & Therapy. 15: 443-51. PMID 24553243 DOI: 10.4161/Cbt.27825 |
0.34 |
|
| 2014 |
Chacko AM, Li C, Nayak M, Mikitsh JL, Hu J, Hou C, Grasso L, Nicolaides NC, Muzykantov VR, Divgi CR, Coukos G. Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 500-7. PMID 24525208 DOI: 10.2967/Jnumed.113.121905 |
0.356 |
|
| 2014 |
Ye Q, Song DG, Poussin M, Yamamoto T, Best A, Li C, Coukos G, Powell DJ. CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 44-55. PMID 24045181 DOI: 10.1158/1078-0432.Ccr-13-0945 |
0.305 |
|
| 2014 |
Li C, Wang J, Matthaiou EI, Guo Y, Hu J, Chacko AM, Muzykantov VR, Coukos G. Immuno-imaging and -therapy in ovarian cancer and sarcoma with de novo single-chain fv-fc fusion protein targeting TEM1/CD248 Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P219 |
0.382 |
|
| 2013 |
Chacko AM, Li C, Pryma DA, Brem S, Coukos G, Muzykantov V. Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide. Expert Opinion On Drug Delivery. 10: 907-26. PMID 23751126 DOI: 10.1517/17425247.2013.808184 |
0.314 |
|
| 2013 |
Hu X, Guo J, Zheng L, Li C, Zheng TM, Tanyi JL, Liang S, Benedetto C, Mitidieri M, Katsaros D, Zhao X, Zhang Y, Huang Q, Zhang L. The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Molecular Cancer Research : McR. 11: 240-50. PMID 23339187 DOI: 10.1158/1541-7786.Mcr-12-0432 |
0.323 |
|
| 2013 |
Li C, Wang J, Hu J, Chacko AM, Zhao A, Divgi C, Muzykantov V, Coukos G. Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248 Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P81 |
0.369 |
|
| 2013 |
Li C, Hu J, Chacko AM, Wang J, Zhao A, Duan X, Muzykantov V, Coukos G. Abstract B68: Targeted theranostics of tumor vasculature by multivalent scFv constructs against TEM1 Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B68 |
0.375 |
|
| 2011 |
Li C, Sasaroli D, Chen X, Hu J, Sandaltzopoulos R, Omidi Y, Coukos G. Tumor vascular biomarkers: new opportunities for cancer diagnostics. Criminal Behaviour and Mental Health. 8: 253-271. PMID 22045357 DOI: 10.3233/Cbm-2011-0217 |
0.332 |
|
| 2011 |
Zhao A, Nunez-Cruz S, Li C, Coukos G, Siegel DL, Scholler N. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform Journal of Immunological Methods. 363: 221-232. PMID 20837020 DOI: 10.1016/J.Jim.2010.09.001 |
0.336 |
|
| 2010 |
Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Bützow R, Coukos G, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. Plos One. 5: e10277. PMID 20422001 DOI: 10.1371/Journal.Pone.0010277 |
0.35 |
|
| 2008 |
Yang N, Huang J, Greshock J, Liang S, Barchetti A, Hasegawa K, Kim S, Giannakakis A, Li C, O'Brien-Jenkins A, Katsaros D, Bützow R, Coukos G, Zhang L. Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment. Plos One. 3: e1758. PMID 18335034 DOI: 10.1371/Journal.Pone.0001758 |
0.341 |
|
| Show low-probability matches. |